logo-loader

Collagen Solutions applies for European approval after successful ChondroMimetic study

Published: 08:06 21 Feb 2018 GMT

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS), discusses with Proactive the successful results from an eight-year extension clinical study of patients who received ChondroMimetic® implants for the repair of cartilage defects in the knee.

Rushdy says the positive results have now allowed them to submit an initial submission for a CE Mark.

Morning Report: Vaccines and EU package lift FTSE 100

Headlines from the Proactive UK newsroom. The FTSE 100 was in better heart as yesterday’s vaccine news and €750bn EU bail-out package helped sentiment. The blue-chip index rose 43 points to 6,305. Grocery tills were their busiest ever over the past 12 weeks according to market research...

on 21/7/20